Topics
March 2012 | Perspectives: from The Editors Of New Retina Md
The Sunshine Act's Intimidation Factor
Will the noble objectives of this law set up a roadblock to innovation?
Richard S. Kaiser, MD, and Jonathan L. Prenner, MD
April 23, 2026
Nanoscope Therapeutics Showcases Vision Restoration Advances at ARVO 2026
Bausch + Lomb Highlights Role of B Vitamins in Reducing AMD Risk in New Scientific Review
OpenAI Launches ChatGPT for Clinicians with New Healthcare-Focused Capabilities
PulseSight Therapeutics to Present First-in-Human PST-611 Trial Results at ARVO
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar
